MAPT and Alzheimer disease: We used this electrostatic model of tau LLPS as a starting point for designing phosphomimetic tau441 variants in which Ser/Thr residues found to be phosphorylated in AD (13, 14, 15) in different protein regions are substituted with Asp or Glu, respectively.